QUADRANT CAPITAL GROUP LLC - Takeda Pharma sedol B01DRX9 US ownership

Takeda Pharma sedol B01DRX9 US's ticker is and the CUSIP is J8129E108. A total of 1 filers reported holding Takeda Pharma sedol B01DRX9 US in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of Takeda Pharma sedol B01DRX9 US
ValueSharesWeighting
Q1 2020$160,000
+41.6%
5,200
+79.3%
0.03%
+92.9%
Q4 2019$113,000
+14.1%
2,9000.0%0.01%
-6.7%
Q3 2019$99,0002,9000.02%
Other shareholders
Takeda Pharma sedol B01DRX9 US shareholders Q1 2020
NameSharesValueWeighting ↓
QUADRANT CAPITAL GROUP LLC 5,200$160,0000.03%
View complete list of Takeda Pharma sedol B01DRX9 US shareholders